Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae

Nan Yao Lee, Wei Han Huang, Ko Chung Tsui, Po Ren Hsueh, Wen Chien Ko

研究成果: Article同行評審

19 引文 斯高帕斯(Scopus)

摘要

For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae treated by ertapenem (73, 29.9%) or either imipenem or meropenem (171, 70.1%), the therapeutic efficacy was evaluated. Ertapenem therapy was effective for patients with ESBL-producing E. coli or K. pneumoniae bacteremia in terms of mortality and microbiological responses, as compared with imipenem or meropenem.

原文English
頁(從 - 到)150-153
頁數4
期刊Diagnostic Microbiology and Infectious Disease
70
發行號1
DOIs
出版狀態Published - 2011 五月

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

指紋 深入研究「Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae」主題。共同形成了獨特的指紋。

引用此